Suchergebnisse - "Corre, Romain"

PubPharm (9)

1

Machine Learning-Based Analysis of Treatment Sequences Typology in Advanced Non-Small-Cell Lung Cancer Long-Term Survivors Treated With Nivolumab

enthalten in: JCO clinical cancer informatics | 2022

von Chouaïd, C. | Grumberg, V. | Batisse, A. | +7

2

Brief Report on the Efficacy of Nivolumab in Patients With Previously Treated Advanced Large-Cell Neuroendocrine Cancer of the Lung

enthalten in: JTO clinical and research reports | 2021

von Agar, C. | Geier, M. | Léveiller, G. | +8

3

Duration of nivolumab for pretreated, advanced non-small-cell lung cancer

enthalten in: Cancer medicine | 2020

von Geier, M. | Descourt, R. | Corre, R. | +12

4

Immune-related Encephalitis in Two Patients Treated With Immune Checkpoint Inhibitor

enthalten in: Clinical lung cancer | 2020

von Robert, L. | Langner-Lemercier, S. | Angibaud, A. | +5

5

Coeliac-Like Disease Is a Rare Immune-Related Complication Induced by Nivolumab in NSCLC

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2020

von Kokorian, R. | Grainville, T. | Robert, L. | +4

6

Immunotherapy rechallenge after nivolumab treatment in advanced non-small cell lung cancer in the real-world setting : A national data base analysis

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2020

von Giaj Levra, M. | Cotté, F. | Corre, R. | +8

7

Nivolumab plus ipilimumab versus chemotherapy as first-line treatment in advanced non-small-cell lung cancer with high tumour mutational burden : patient-reported outcomes results from the randomised, open-label, phase III CheckMate 227 trial

enthalten in: European journal of cancer (Oxford, England : 1990) | 2019

von Reck, M. | Schenker, M. | Lee, K. | +18

8

Nivolumab or nivolumab plus ipilimumab in patients with relapsed malignant pleural mesothelioma (IFCT-1501 MAPS2) : a multicentre, open-label, randomised, non-comparative, phase 2 trial

enthalten in: The Lancet. Oncology | 2019

von Scherpereel, A. | Mazieres, J. | Greillier, L. | +22

CommentIn: Lancet Oncol. 2019 Feb;20(2):172-174. - PMID 30660608

9

enthalten in: Bulletin du cancer | 2018

von Frelau, A. | Pracht, M. | Le Sourd, S. | +6

1
[1]